Cargando…
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
Methylation of histone 3 at lysine 79 (H3K79) is one of the principal mechanisms involved in gene expression. The histone methyltransferase DOT1L, which mono-, di- and trimethylates H3K79 using S-adenosyl-L-methionine as a co-factor, is involved in cell development, cell cycle progression, and DNA d...
Autores principales: | Sarno, Federica, Nebbioso, Angela, Altucci, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188393/ https://www.ncbi.nlm.nih.gov/pubmed/31790636 http://dx.doi.org/10.1080/15592294.2019.1699991 |
Ejemplares similares
-
3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
por: Sarno, Federica, et al.
Publicado: (2018) -
Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway
por: Sarno, Federica, et al.
Publicado: (2020) -
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets
por: Santaniello, Giovanna, et al.
Publicado: (2022) -
Sirtuins and Disease: The Road Ahead
por: Carafa, Vincenzo, et al.
Publicado: (2012) -
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
por: Carafa, Vincenzo, et al.
Publicado: (2019)